- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients ; day:8 ; month:11 ; year:2016 ; pages:1-6
European journal of nuclear medicine and molecular imaging ; (8.11.2016), 1-6
- Creator
- Contributor
-
Lengana, Thabo
Modiselle, Moshe
Vorster, Mariza
Zeevaart, JanRijn
Maes, Alex
Ebenhan, Thomas
Wiele, Christophe Van de
SpringerLink (Online service)
- DOI
-
10.1007/s00259-016-3563-6
- URN
-
urn:nbn:de:1111-2016120116865
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sathekge, Mike
- Lengana, Thabo
- Modiselle, Moshe
- Vorster, Mariza
- Zeevaart, JanRijn
- Maes, Alex
- Ebenhan, Thomas
- Wiele, Christophe Van de
- SpringerLink (Online service)
Other Objects (12)
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Einfluss der 68Ga-HBED-CC PSMA PET/CT auf Diagnostik und Therapiemanagement des Prostatakarzinoms
Der diagnostische Nutzen der 68Ga-PSMA-HBED-CC PET/CT in der Primärdiagnostik des Prostatakarzinoms
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
[68Ga]PSMA-PET/CT-imaging bij de diagnostiek van prostaatkanker
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
Der Stellenwert der 68Ga-PSMA-PET/CT im Therapiemanagement des Prostatakarzinoms
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Einfluss der 68Ga-HBED-CC PSMA PET/CT auf Diagnostik und Therapiemanagement des Prostatakarzinoms
Der diagnostische Nutzen der 68Ga-PSMA-HBED-CC PET/CT in der Primärdiagnostik des Prostatakarzinoms
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
[68Ga]PSMA-PET/CT-imaging bij de diagnostiek van prostaatkanker
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
Der Stellenwert der 68Ga-PSMA-PET/CT im Therapiemanagement des Prostatakarzinoms
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma
Gross tumor volume delineation in primary prostate cancer on 18F-PSMA-1007 PET/MRI and 68Ga-PSMA-11 PET/MRI
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Einfluss der 68Ga-HBED-CC PSMA PET/CT auf Diagnostik und Therapiemanagement des Prostatakarzinoms
Der diagnostische Nutzen der 68Ga-PSMA-HBED-CC PET/CT in der Primärdiagnostik des Prostatakarzinoms
Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
[68Ga]PSMA-PET/CT-imaging bij de diagnostiek van prostaatkanker
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
Der Stellenwert der 68Ga-PSMA-PET/CT im Therapiemanagement des Prostatakarzinoms
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma